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Nuclear DNA Analysis in Neuroblastoma 
-Significance of DNA Ploidy as a Prognostic Factor-
Tsutomu Sakai
First Department of Surgery, Nagasaki University School of Medicine
 The nuclear DNA content was measured by using flow 
cytometer from paraffin-embedded pathological materials 
in neuroblastomas. 
 In 55 neuroblastomas, diploidy pattern was found in 26 
(47.6%). In contrast, aneuploidy was in 29 (52.7%). The 
prognosis of aneuploidy pattern is more satisfactory than 
that of diploidy. 
 However, aneuploidy pattern included 62% of stage I, II, 
and IVs patients, 77.8% of less than the first year of age, 
20% of N-myc amplification. There was unevenness of the 
patient's background between diploidy and aneuploidy 
patterns.
Introduction 
 Neuroblastoma is one of the infantile representative solid 
tumors with poor prognosis. It is reported that a part of 
neuroblastoma accomplishes a tendency toward sponta-
neous remission." Their prognoses vary so much with 
patients' ages, disease stages and tumor locations, that 
understanding of biologic characteristics is required for the 
treatment of neuroblastoma. 
  Recent studies were focused on chromosomal aberration 
and N-myc expression.'-" On the other hand, DNA analys-
tic studies are scanty.6-9) 
 The purpose of this study is to clarify the validity of 
DNA analysis for neuroblastomas to predict their prog-
noses.
Method 
 Three or four slices of 50,um thick were cut from a 
paraffin embedded block and processed by the method of 
B. Schutte et al"' and the preparation was stained by 
Propidium Iodide (PI) by the method of Vindelq5v.12' In this 
study over seven of coefficient of variation (CV) were 
excluded. 
 The DNA index (DI) was determined based on the 
resultant histogram. Diploidy was defined as DI = 1.0 
whereas aneuploid as DI 1.0. A significant difference 
was assessed by X2-test and by Wilcoxon test for cumu-
lative survival rates. A difference of p < 0.05 was regarded 
as statistically significant.
Results 
 In the six patients DNA analysis was made at varying 
period of pretreatment, recurrence, metastasis and autopsy. 
It was convenient for evaluating the response to the prior 
treatment of chemoterapy. There was no change in DNA 
patterns among tumor locations. 
 In this study five cases were excluded for the reasons of 
unsuitable CV and undeterminable peak delineated on 
histogram. A suitable DNA histogram (Fig. 1) was obtained
Material and Method 
Material 
 During the 14 years from 1974 to 1987, 60 surgical 
specimens were subjected in this study at the First Depart-
ment of Surgery, Nagasaki University School of Medicine 
and the Pediatric Surgery, Faculty of Medicine, Kyushu 
University. 
 The 180 samples from the 60 neuroblastomas were 
investigated in this series. Fig. 1. DNA histogram
in 40 of neuroblastoma and 15 of ganglioneuroblastoma. 
 The DNA ploidy patterns obtained in this study were 
evaluated in terms of clinical and histologic backgrounds in 
accordance with the rule of Japanese pediatric tumor study 
of pathology. The CV values in 55 patients averaged 4.67 
± 1.48. 
1) The incidence of DNA ploidy 
 Of 55 neuroblastomas, 26 (47.3%) were the diploidy 
pattern and 29 (52.7%) were aneuploidy. The distribution 
of DNA ploidy patterns was shown in Fig. 2. Aneuploid 
distributed from 1.1 to 2.5 of DI. A range from 1.3 to 1.7. 
  Over '2.0 of DI (more than 4C of DNA content) were 
seen in five cases.
in 14 (77.8%) with a significant difference. According to 
disease stages, the diploidy pattern was seen only in two of 
stage I and IVs. The others were of aneuploidy pattern. In 
37 cases over one year old, 22 (59.5%) showed the di-
ploidy pattern, 15 (40.5%) were aneuploidy without statis-
tically significant difference as shown in Table 2.
Table 2. Stage, ploidy and age
              under 1 year age over 1 year of age 
          D A D A
   I 2 5 1 0 
   II 0 2 3 3
   III 0 3 8 2
   IVA 0 1 8 8
   IVB 0 1 2 1 
   IV, 2 2 0 1
           4 14 22 15
D; diploidy 
A; aneuploidy
Fig. 2. Frequency of DNA index
i) The incidence according to disease stages. 
 The diploidy pattern of 21. belonging to stage I, II, IVs 
was seen in eight (38.0%). On the other hand, the aneu-
ploidy pattern was shown in 13 (62.0%). In stage III, the 
diploidy pattern was in 61.5%, aneuploidy in 38.5%. 
 In stage IVA and IVB, a similar distribution was shown. 
However, the incidence of the diploidy pattern had become 
higher with advances in disease stages as shown in Table 1.
iii) Association with tumor location. 
 In case of the origin of the adrenal gland, the diploidy 
pattern was seen in 13 (44.8%) out of 29, aneuploidy in 16 
(55.2%). On the other hand, in 26 of the origins except for 
the adrenal gland. There was no significant difference 
between the incidence of diploidy and aneuploidy patterns 
as shown in Table 3.
Table 3. Tumor location and ploidy
                  diploidy aneuploidy 
adrenal 13 16 29 
retroperitoneum 8 7 15 
posterior mediastinum 4 5 9 
others 1 1 2
Table 1. Stage and ploidy
             diploidy aneuploidy 
   I 3(3) 5(5) 8(8) 
   II 3(l) 5( 5) 8( 6) 
   III 8(2) 5 ( 4) 13( 6) 
   IVA 8(0) 9 ( 2) 17( 2) 
   IV, 2(1) 2( 1) 4( 2) 
   IV, 2(2) 3 ( 1) 5 ( 3) 
           26(9) 29(18) 55(27)
( ); alive
iv) Relationship between local invasion and metastasis. 
 With respect to the type of local invasion which had 
been described in the chart, there was no significant pattern 
between locally invasive types and DNA ploidy patterns. 
 In cases with n2 of nodal metastasis, the diploidy pattern 
was seen in 62.5%, in contrast, aneuploidy in 37.5% in case 
with n3 of nodal involvement. The incidence of aneuploidy 
pattern had become higher and there is a high tendency 
toward occurring distant metastasis. In contrast, there is no 
close correlation between the types metastasis and ploidy 
patterns as shown in Table 4.
ii) Relationship between ages and disease stages. 
 Among 18 cases of age under one year, the diploidy 
pattern was found in four (22.2%), the aneuploidy pattern
Table 4. Local invasion, metastasis and ploidy
               diploidy aneuploidy 
C 0 
       1 3 8 
       2 3 5
       3 10 8
N 0 5 10 
       1 1 2
       2 8 2
       3 2 6
          x 1 
B 0 12 17 
       1 4 4
E 0 16 20 
       1 0 1 
V 0 15 19 
       1 1 2
bm 0 14 18 
       1 2 3
H 0 15 18 
       1 0 0
       2 0 0
       3 1 3
D 0 16 19 
       1 0 2
vi) Relationship between N-myc amplification and ploidy 
patterns. 
 The examinations of N-myc oncogenes were made in 25 
specimens. Of 25, ten were amplificated in N-myc oncogen 
in which eight out of 11 had the diploidy pattern and two 
out of 14 were aneuploidy. 
 N-myc amplification failed to be found in patients under 
one year of the first life. All of positive N-myc expressions 
were over one year old as shown in Table 6.
Table 6. N-myc, DNA ploidy and ages
    N ages under 1 year over l year      -myc 
             diploidy aneuploidy diploidy aneuploidy 
amplification (-) 2(2) 8(8) 1 (1) 4(1) 
amplification (+) 0 0 8(0) 2(0) 
( ); alive
2) Relationship between the prognosis and ploidy patterns 
 The survivors were 27 (49.1%) out of 55 in this series. 
Fig. 3 shows the cumulative survival curve in accordance 
with the disease stages. There was no death in stage I. The 
prognosis had become aggravated with advances in disease 
stages. 
 The prognoses for stage I and II were significantly fair 
(p < 0.05) when compared with those of stage IV,,.
v) Relationship between pathologic types and ploidy pat-
terns. 
 In 40 neuroblastomas, the incidence of diploidy pattern 
was equivalent to that of aneuploidy. In contrast, in gan-
glioneuroblastomas, aneuploidy pattern was seen in nine 
(60%) out of 15. In particular, aneuploidy pattern was not 
infrequently seen in poorly differentiated ganglioneu-
roblastomas. 
 There was a tendency of demonstrating diploidy pattern 
in accordance with progression of differentiation. There 
was no significant trend in the other histological types as 
shown in Table 5.
Fig. 3. Cumulative survival curve according to disease stages
Table 5. Histology and ploidy
                         diploidy aneuploidy 
 Neuroblastoma 20(6) 20(12) 
  round cell type 2(0) 1 ( 0) 
   rosette-fibrillary type 18(6) 19(12)
 Ganglioneuroblastoma 6(3) 9 ( 6) 
   poorly differentiated type 1(0) 8 ( 6) 
   composite type 2(1) 0 
  well differentiated type 3(2) 1 ( 0) 
( ); alive
i) As for ploidy patterns, of 26 with the diploidy pattern, 
nine (34.6%) survived. In contrast, 18 (62.1%) out of 29 
with the aneuploidy pattern were alive. 
 The cumulative survival curve is shown in Fig. 4. The 
prognosis of the aneuploidy pattern was significantly satis-
factory (p < 0.05).
Fig. 4. Cumulative survival curve according to ploidy patterns
ii) With respect to disease stages, the prognosis of stage I 
was fair without any difference between those of diploidy 
and aneuploidy patterns. On the contrary, the prognoses of 
stage II, III in aneuploidy patterns were fair (Fig. 5) but it 
was not a statistically significant difference between the 
two patterns in stage IV,, and IVB (Fig. 6). 
iii) Concerning boy's and girl's ages, the prognosis of 
patients under 12 months of the first life was extremely fair 
in both patterns without a significant difference. On the 
other hand, in the prognosis of patients over one year old, 
the prognosis of the aneuploidy pattern was significantly 
satisfactory (p < 0.05) when compared with that of the 
diploidy pattern as shown in Fig. 7. 
iv) According to the locations of primary tumors, the 
prognoses of extra-adrenal origin tumors were better than 
those of adrenal origin tumors. 
  There was no constant inclination of ploidy patterns. 
v) Relationship between invasive types and their metastasis 
and ploidy patterns. 
  There was no specific patterns concerning invasive types 
and their metastasis in accordance with diploidy and aneu-
ploidy patterns. 
vi) Relationship between histologic types and ploidy pat-
terns. 
 The prognosis of the aneuploidy pattern was fair in 
every histologic types. There was no close correlation 
between histologic types and their prognosis. 
vii) Relationship between N-myc oncogen expression and 
ploidy patterns. 
 In this series amplification of N-myc was seen in 10 in 
whom no survival was experienced.
Fig. 5. Cumulative survival curve according to ploidy patterns in 
stage II and III
Fig. 6. Cumulative survival curve according to ploidy patterns in 
stage IV AB
Fig. 7. Cumulative survival curve according to ploidy patterns in 
babies under 1 year of age
Discussion 
  It is known that the prognosis of neuroblastoma in infant 
is divided into the fair prognosis group (under one year of 
life, stage I, II and IV,) and the unfair prognosis group 
(over one year old, stage III and IVB and stage IV,,) through 
ages. It is now accepted that a significant difference in 
biologic behavior exist in the two groups." Fifty-five sub-
jected to this study were divided into the two groups. 
Recently, it has become possible to know the prognosis in 
more detail and more accuracy. 
 Trials to elucidate biologic behavior of malignancy have 
been made by DNA measurement using microphoto-
spectrometry 14 15) and flow cytometry.'"I 
  Hedley"' developed DNA measurement from paraffin-
embedded samples, which contributed to retrospective 
study for assessment of malignancy. It is widely ac-
cepted"" that prognosis of patients with the diploidy 
pattern is much more satisfactory than that with the aneu-
ploidy one. On the contrary, some investigators"" reported 
that the aneuploidy pattern in neuroblastoma showed a 
good progosis. In this study, DNA ploidy patterns were 
evaluated in 55 neuroblastomas in analysis of prognostic 
factors. Cumulative survival curve revealed a fair survival 
in the aneuploidy pattern (p < 0.05). In the analysis of the 
fair prognosis group, it included the aneuploidy pattern in 
babies of less than the first year of life as well as in stage 
III, IV,, and through the entire ranges of ages. 
  It is assumed that the aneuploidy pattern is shown in 
70% to 80% of stage I, II and IV, and babies under 12 
month of birth. There was no close correlation among the 
modes of local invasion and metastasis and the ploidy 
pattern. 
  In the chromosomal analysis, there was a high incidence 
of hyperploidy and also a loss of 14q was defined. At the 
same time, it has become apparent that Ha-ras expression 
reflects a fair prognosis."' In cases with poor prognosis, it 
is characteristic of demonstration of a diploidy pattern and 
aberration of 1 p.2" It is reported that N-myc expression was 
seen in stage III and IV, exceptionally in stage I and 1I23'. 
Amplification of N-myc oncogen well correlates with poor 
prognosis." Of 25 with N-myc investigation, amplification 
of N-myc oncogen was seen in 10 in this series in whom 
aneuploidy pattern was not revealed. However, it is empha-
sized that the outcome is in association with ages, disease 
stages and N-myc expression. The aneuploidy pattern does 
not necessarily indicate a fair prognosis. It is not clear as to 
what means the deviation to aneuploidy patterns of fair 
prognosis. In general, the tumors with aneuploidy pattern 
implies activated proliferation of cells. Mass screening in 
newborn makes it possible to detect and manage this tumor 
early. The tumor indicating the diploidy pattern showed a 
low proliferation. On the other hand, chance of treating 
advanced case is frequent because it is difficult to be 
detected early. There is no great difference in the prognosis
between diploidy and aneuploidy patterns. The possibility 
to make a fair prognosis for tumors of the aneuploidy 
pattern exist in the use of potent chemotherapy which 
reveals a high sensitivity to aneuploid tumors. In conclu-
sion, DNA ploidy analysis has a great value in judging 
biologic behavior of the tumors and a further study is 
necessary for clarifying heterogeneity and for knowing the 
change with the passage of time.
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